WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Regeneron and TriNetX announced a strategic collaboration giving Regeneron an exclusive opportunity to connect genomic and proteomic cohorts to TriNetX’s network of approximately 300 million de-identified electronic health records. The agreement includes secure licensed data access and a potential Regeneron investment of up to $200 million in TriNetX.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- Tarrytown, New York / Cambridge, Massachusetts, United States
- Source checked
- September 25, 2026
FOLLOW THE STORY